Glioblastoma study discovers protective role of metabolic enzyme, revealing a novel therapeutic target
Patient reporting of possible cancer symptoms fell during first wave of pandemic
26 May 2021Infrared thermal imaging as a novel non-invasive point-of-care tool to assess filarial lymphoedema
26 May 2021Glioblastoma study discovers protective role of metabolic enzyme, revealing a novel therapeutic target
Researchers at The University of Texas MD Anderson Cancer Center have discovered a novel function for the metabolic enzyme medium-chain acyl-CoA dehydrogenase (MCAD) in glioblastoma (GBM). MCAD prevents toxic lipid buildup, in addition to its normal role in energy production, so targeting MCAD causes irreversible damage and cell death specifically in cancer cells.
